Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
2.34%
0%
2.34%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Hangzhou Diagens Biotechnology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
74.80%
EBIT Growth (5y)
-54.12%
EBIT to Interest (avg)
-30.53
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
149.17
EV to EBIT
-314.53
EV to EBITDA
-364.38
EV to Capital Employed
207.43
EV to Sales
154.12
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-65.95%
ROE (Latest)
-39.63%
Technicals key factors
Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
KST
Dow Theory
Mildly Bearish
OBV
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
178.30
76.30
133.68%
Operating Profit (PBDIT) excl Other Income
-75.40
-20.00
-277.00%
Interest
0.60
23.00
-97.39%
Exceptional Items
0.30
0.40
-25.00%
Consolidate Net Profit
-72.80
-47.00
-54.89%
Operating Profit Margin (Excl OI)
-490.00%
-456.20%
-3.38%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 133.68% vs 30.65% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -54.89% vs 24.19% in Dec 2024






